Clinical Trial Update: A Study of Safety and Effectiveness of Bendamustine Hydrochloride in Adult Filipino Patients With Chronic Lymphocytic Leukemia

View source ↗

Summary

This clinical trial evaluating bendamustine hydrochloride for chronic lymphocytic leukemia in adult Filipino patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine Hydrochloride (bendamustine)

Snippet

Sponsor: Janssen Pharmaceutica | Conditions: Chronic Lymphocytic Leukemia | Status: WITHDRAWN